Literature DB >> 19859015

Nasopharyngeal acute phase cytokines in viral upper respiratory infection: impact on acute otitis media in children.

Janak A Patel1, Sangeeta Nair, Krystal Revai, James Grady, Tasnee Chonmaitree.   

Abstract

BACKGROUND: The role of acute phase cytokines generated in the nasopharynx during viral upper respiratory infection (URI) in subsequent development of acute otitis media (AOM) has not been examined.
METHODS: We studied 326 virus-positive URI episodes in 151 children aged 6-36 months. Nasopharyngeal secretions collected within 1 to 7 days of URI onset were studied for viruses by conventional and molecular techniques, and for concentrations of IL-1beta, IL-6, and TNFalpha by multiplex enzyme-linked immunosorbent assay. Children were followed up for 28 days to document AOM complication.
RESULTS: IL-1beta, IL-6, and TNFalpha concentrations correlated positively with each other (P<0.001). IL-6 and TNFalpha concentrations were higher in males than in females (P=0.01 and 0.02). IL-6 and TNFalpha concentrations were inversely correlated with age (P=0.02 and 0.05). IL-6 concentrations correlated positively with duration of fever (P=0.006) and correlated negatively with the number of days of URI symptoms (P=0.026). Furthermore, IL-6 concentrations were significantly higher during adenovirus and influenza virus URIs as compared with enterovirus and rhinovirus URIs (P<0.01). IL-1beta concentrations were higher during URI episodes with AOM than those without AOM (P<0.001).
CONCLUSIONS: We found IL-6 nasopharyngeal secretions concentrations to be higher with adenovirus and influenza infection, and in children with systemic febrile response during URI. However, IL-1beta was found to play a more important role in the development of AOM after URI. Additional studies are needed to further define the role of acute phase cytokines in virus-induced AOM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19859015      PMCID: PMC3220942          DOI: 10.1097/INF.0b013e3181aa5b13

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  17 in total

1.  A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants.

Authors:  R Y Sung; S H Hui; C K Wong; C W Lam; J Yin
Journal:  Eur J Pediatr       Date:  2001-02       Impact factor: 3.183

2.  Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients.

Authors:  D A Gentile; J Yokitis; B L Angelini; W J Doyle; D P Skoner
Journal:  Ann Allergy Asthma Immunol       Date:  2001-05       Impact factor: 6.347

3.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

4.  Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.

Authors:  L Kaiser; R S Fritz; S E Straus; L Gubareva; F G Hayden
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

5.  Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease.

Authors:  P Sheeran; H Jafri; C Carubelli; J Saavedra; C Johnson; K Krisher; P J Sánchez; O Ramilo
Journal:  Pediatr Infect Dis J       Date:  1999-02       Impact factor: 2.129

6.  Nasal cytokine production in viral acute upper respiratory infection of childhood.

Authors:  T L Noah; F W Henderson; I A Wortman; R B Devlin; J Handy; H S Koren; S Becker
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

7.  Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.

Authors:  Federico R Laham; Victor Israele; Javier M Casellas; Alejandro M Garcia; Carlos M Lac Prugent; Scott J Hoffman; Debra Hauer; Bhagvanji Thumar; Maria Ivonne Name; Andres Pascual; Natalia Taratutto; Maria T Ishida; Marcela Balduzzi; Miguelina Maccarone; Susana Jackli; Roberto Passarino; Raul A Gaivironsky; Ruth A Karron; Norberto R Polack; Fernando P Polack
Journal:  J Infect Dis       Date:  2004-05-06       Impact factor: 5.226

8.  Cytokines in nasopharyngeal secretions; evidence for defective IL-1 beta production in children with recurrent episodes of acute otitis media.

Authors:  K Lindberg; B Rynnel-Dagöö; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

Review 9.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

10.  Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex).

Authors:  J Fan; K J Henrickson; L L Savatski
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

View more
  20 in total

Review 1.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

2.  Acute otitis media severity: association with cytokine gene polymorphisms and other risk factors.

Authors:  David P McCormick; James J Grady; Alejandro Diego; Reuben Matalon; Krystal Revai; Janak A Patel; Yimei Han; Tasnee Chonmaitree
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2011-03-26       Impact factor: 1.675

Review 3.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 4.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

5.  Childhood infections and adult height in monozygotic twin pairs.

Authors:  Amie E Hwang; Thomas M Mack; Ann S Hamilton; W James Gauderman; Leslie Bernstein; Myles G Cockburn; John Zadnick; Kristin A Rand; John L Hopper; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2013-04-12       Impact factor: 4.897

6.  Association of cytokine gene polymorphisms and risk factors with otitis media proneness in children.

Authors:  Olivera Miljanović; Bojana Cikota-Aleksić; Dragan Likić; Danilo Vojvodić; Ognjen Jovićević; Zvonko Magić
Journal:  Eur J Pediatr       Date:  2016-03-09       Impact factor: 3.183

7.  Impaired Proinflammatory Response in Stringently Defined Otitis-prone Children During Viral Upper Respiratory Infections.

Authors:  Dabin Ren; Qingfu Xu; Anthony L Almudevar; Michael E Pichichero
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

8.  Antimicrobial Activity of Garlic Derivatives on Common Causative Microorganisms of the External Ear Canal and Chronic Middle Ear Infections.

Authors:  Lokman Uzun; Tuba Dal; M Tayyar Kalcıoğlu; Merve Yürek; Ziya Cibali Açıkgöz; Rıza Durmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2019-12-01

Review 9.  Viral-bacterial interactions in acute otitis media.

Authors:  Tal Marom; Johanna Nokso-Koivisto; Tasnee Chonmaitree
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

10.  Lactate dehydrogenase as a marker of nasopharyngeal inflammatory injury during viral upper respiratory infection: implications for acute otitis media.

Authors:  Linda C Ede; James O'Brien; Tasnee Chonmaitree; Yimei Han; Janak A Patel
Journal:  Pediatr Res       Date:  2012-11-30       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.